810130C

16:0-06:0 NBD PC

Avanti Research^™ - A Croda Brand 810130C

• Synonym(e): 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-3-phosphocholine
• Empirische Formel (Hill-System): C₃₆H₆₂N₅O₁₁P
• CAS-Nummer: 91992-01-7
• Molekulargewicht: 771.88
• MDL-Nummer: MFCD00067469
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: liquid
• Verpackung: pkg of 1 × 1 mL (810130C-1mg); pkg of 5 × 1 mL (810130C-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand 810130C
• Konzentration: 1 mg/mL (810130C-1mg); 1 mg/mL (810130C-5mg)
• Versandbedingung: dry ice
• Lagertemp.: −20°C

Beschreibung

Allgemeine Beschreibung

Phosphocholine is considered as a precursor molecule. It is formed during the breakdown of phosphatidylcholine (PC) metabolism. 16:0-06:0 NBD PC is a fluorescent lipid.

Anwendung

16:0-06:0 NBD PC I suitable for use:

• in the preparation of fluid phase fluorescent bilayers
• to prepare liposomes/small unilamellar vesicles (SUVs)
• as substrate in in vitro enzyme assay of lipoteichoic acid (LTA) synthase enzyme (LtaS) to determine the enzyme specificity

Verpackung

5 mL Amber Glass Screw Cap Vial (810130C-1mg)

5 mL Amber Glass Screw Cap Vial (810130C-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Piktogramme: GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H302,H315,H319,H331,H336,H351,H361d,H372,H412
• P-Sätze: P201 - P273 - P301 + P312 + P330 - P302 + P352 - P304 + P340 + P311 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 3 - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• Zielorgane: Central nervous system, Liver,Kidney
• WGK: WGK 3